CURE Pharmaceutical To Buy CBD Company Sera Labs For $20M
Pharmaceutical company CURE Pharmaceutical Holdings (OTCQB: CURR) agreed to acquire CBD products company Sera Labs Inc. for an up-front payment of $20 million.
The price tag includes $1 million in cash and $19 million in CURE stock.
